Realizable protocols for optimal administration of drugs in mathematical models for anti-angiogenic treatment

Mathematical Medicine and Biology

Volumn 27, Issue 2, 2010, Pages 157-179

  Ledzewicz, Urszula ^a   Marriott, John ^a   Maurer, Helmut ^b   Schättler, Heinz ^c  

^a SOUTHERN ILLINOIS UNIVERSITY EDWARDSVILLE   (United States)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

Author keywords

Biomathematical modelling; Optimal control; Realizable protocols; Tumour anti angiogenesis

Indexed keywords

CONTROLLED DRUG DELIVERY; OPTIMAL CONTROL SYSTEMS;

ANGIOGENESIS; BIOMATHEMATICAL MODELS; DYNAMICAL THEORY; INITIAL CONDITIONS; OPTIMAL CONTROLS; OPTIMAL SOLUTIONS; REALIZABLE PROTOCOL; TUMOR ANTI-ANGIOGENESIS; TUMOR DEVELOPMENT; TUMOR GROWTH;

TUMORS;

EID: 77955693734     PISSN: 14778599     EISSN: 14778602     Source Type: Journal    
DOI: 10.1093/imammb/dqp012     Document Type: Article

References (32)

1. AGUR, Z., ARAKELYAN, L., DAUGULIS, P. & GINOSAR, Y. (2004) Hopf point analysis for angiogenesis models. Discrete Continuous Dyn. Syst. Ser. B, 4, 29-38.
2. ANDERSON, A. & CHAPLAIN, M. (1998) Continuous and discrete mathematical models of tumor-induced angiogenesis. Bull. Math. Biol., 60, 857-899.
3. ANDERSON, A., CHAPLAIN, M., GARCIA-REIMBERT, M. & VARGAS, C. (2000) A gradient-driven mathematical model of anti-angiogenesis. Math. Comput. Model., 32, 1141-1152.
4. ARAKELYAN, L., VAINSTAIN, V. & AGUR, Z. (2003) A computer algorithm describing the process of vessel formation and maturation, and its use for predicting the effects of anti-angiogenic and anti-maturation therapy on vascular tumour growth. Angiogenesis, 5, 203ff.
5. BOEHM, T., FOLKMAN, J., BROWDER, T. & O'REILLY, M. S. (1997) Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature, 390, 404ff.
6. BONNARD, B. & CHYBA, M. (2003) Singular Trajectories and their Role in Control Theory. Mathématiques & Applications, vol. 40. Paris, France: Springer.
7. BRESSAN, A. & PICCOLI, B. (2007) Introduction to the Mathematical Theory of Control. Springfield, MO: American Institute of Mathematical Sciences (AIMS).
8. BRYSON, A. E. & HO, Y. C. (1975) Applied Optimal Control. Washington, DC: Hemisphere Publishing.
9. CHAPLAIN, M. & ANDERSON, A. (1997) The mathematical modelling, simulation and prediction of tumourinduced angiogenesis. Invasion Metastasis, 16, 222-234.
10. D'ONOFRIO, A. & GANDOLFI, A. (2004) Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. Math. Biosci., 191, 159-184.
11. D'ONOFRIO, A. & GANDOLFI, A. (2006) The response to antiangiogenic anticancer drugs that inhibit endothelial cell proliferation. Appl. Math. Comput., 181, 1155-1162.
12. ERGUN, A., CAMPHAUSEN, K. & WEIN, L. M. (2003) Optimal scheduling of radiotherapy and angiogenic inhibitors. Bull. Math. Biol., 65, 407-424.
13. FLEMING, W. H. & RISHEL, R. W. (1975) Deterministic and Stochastic Optimal Control. New York: Springer.
14. FOLKMAN, J. (1972) Antiangiogenesis: new concept for therapy of solid tumors. Ann. Surg., 175, 409-416.
15. FOLKMAN, J. (1995) Angiogenesis inhibitors generated by tumors. Mol. Med., 1, 120-122.
16. FORYS, U., KEIFETZ, Y. & KOGAN, Y. (2005) Critical-point analysis for three-variable cancer angiogenesis models. Math. Biosci. Eng., 2, 511-525.
17. HAHNFELDT, P., PANIGRAHY, D., FOLKMAN, J. & HLATKY, L. (1999) Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy. Cancer Res., 59, 4770-4775.
18. KERBEL, R. S. (1997) A cancer therapy resistant to resistance. Nature, 390, 335-336.
19. KERBEL, R. S. (2000) Tumor angiogenesis: past, present and near future. Carcinogensis, 21, 505-515.
20. KLAGSBURN, M. & SOKER, S. (1993) VEGF/VPF: the angiogenesis factor found? Curr. Biol., 3, 699-702.
21. LEDZEWICZ, U., LIU, Y. & SCHÄTTLER, H. (2009a) The effect of pharmacokinetics on optimal protocols for a mathematical model of tumor anti-angiogenic therapy. Proceedings of the 2009 American Control Conference, St. Louis, MO. Piscataway, NJ: IEEE, pp. 1060-1065.
22. LEDZEWICZ, U., MARRIOTT, J., MAURER, H. & SCHÄTTLER, H. (2008) The scheduling of angiogenic inhibitors minimizing tumor volume. J. Med. Inform. Technol., 12, 23-28.
23. LEDZEWICZ, U., MUNDEN, J. & SCHÄTTLER, H. (2009b) Scheduling of angiogenic inhibitors for gompertzian and logistic tumor growth models. Discrete Continuous Dyn. Syst. Ser. B, 12, 415-439.
24. LEDZEWICZ, U. & SCHÄTTLER, H. (2005) A synthesis of optimal controls for a model of tumor growth under angiogenic inhibitors. Proceedings of the 44th IEEE Conference on Decision and Control, Sevilla, Spain. Piscataway, NJ: IEEE, pp. 934-939.
25. LEDZEWICZ, U. & SCHÄTTLER, H. (2007) Anti-Angiogenic therapy in cancer treatment as an optimal control problem. SIAM J. Contr. Optim., 46, 1052-1079.
26. LEDZEWICZ, U. & SCHÄTTLER, H. (2008a) Analysis of a mathematical model for tumor anti-angiogenesis. Opt. Control Appl. Methods, 29, 41-57.
27. LEDZEWICZ, U. & SCHÄTTLER, H. (2008b) Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis. J. Theor. Biol., 252, 295-312.
28. LEDZEWICZ, U. & SCHÄTTLER, H. (2009) On the optimality of singular controls for a class of mathematical models for tumor anti-angiogenesis. Discrete Continuous Dyn. Syst. Ser. B, 11, 691-715.
29. LEDZEWICZ, U., SCHÄTTLER, H. & BERMAN, A. (2009c) On the structure of optimal controls for a mathematical model of tumor anti-angiogenic therapy with linear pharmacokinetics. IEEE Multi-conference on Systems, St. Petersburg, Russia. Piscataway, NJ: IEEE, pp. 71-76.
30. MAURER, H., BüSKENS, C., KIM, J. H. & KAJA, Y. (2005) Optimization techniques for the verification of second-order sufficient conditions for bang-bang controls. Optim. Control Appl. Methods, 26, 129-156.
31. SWIERNIAK, A. (2008) Comparison of control theoretic properties of models of antiangiogenic therapy. Proceedings of the 6th International IASTED Conference on Biomedical Engineering. Anaheim, CA: Acta Press, pp. 156-160.
32. SWIERNIAK, A., GALA, G., GANDOLFI, A. & D'ONOFRIO, A. (2006) Optimization of angiogenic therapy as optimal control problem. Proceedings of the 4th IASTED Conference on Biomechanics (M. Doblare ed.). Anaheim, CA: Acta Press, pp. 56-60.